11 February 2020 · Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.
4 August 2020 · The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…
29 June 2022 · Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
29 June 2022 · Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
29 June 2022 · Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance